ATE554385T1 - Verfahren zur selektiven untersuchung von adiponectin-multimeren - Google Patents

Verfahren zur selektiven untersuchung von adiponectin-multimeren

Info

Publication number
ATE554385T1
ATE554385T1 AT09004308T AT09004308T ATE554385T1 AT E554385 T1 ATE554385 T1 AT E554385T1 AT 09004308 T AT09004308 T AT 09004308T AT 09004308 T AT09004308 T AT 09004308T AT E554385 T1 ATE554385 T1 AT E554385T1
Authority
AT
Austria
Prior art keywords
adiponectin
electrophoresed
kda
sds
exhibits
Prior art date
Application number
AT09004308T
Other languages
English (en)
Inventor
Hiroyuki Ebinuma
Hirokazu Yago
Yuka Akimoto
Osamu Myazaki
Takashi Kadowaki
Toshimasa Yamauchi
Kazuo Hara
Original Assignee
Sekisui Medical Co Ltd
Toudai Tlo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Medical Co Ltd, Toudai Tlo Ltd filed Critical Sekisui Medical Co Ltd
Application granted granted Critical
Publication of ATE554385T1 publication Critical patent/ATE554385T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
AT09004308T 2003-10-15 2004-10-15 Verfahren zur selektiven untersuchung von adiponectin-multimeren ATE554385T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003354930 2003-10-15

Publications (1)

Publication Number Publication Date
ATE554385T1 true ATE554385T1 (de) 2012-05-15

Family

ID=34463157

Family Applications (2)

Application Number Title Priority Date Filing Date
AT04792477T ATE439590T1 (de) 2003-10-15 2004-10-15 Verfahren zum selektiven testen von adiponectinmultimeren
AT09004308T ATE554385T1 (de) 2003-10-15 2004-10-15 Verfahren zur selektiven untersuchung von adiponectin-multimeren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT04792477T ATE439590T1 (de) 2003-10-15 2004-10-15 Verfahren zum selektiven testen von adiponectinmultimeren

Country Status (12)

Country Link
US (2) US7608405B2 (de)
EP (2) EP2071333B1 (de)
JP (1) JP4677545B2 (de)
KR (1) KR101206338B1 (de)
CN (1) CN1867828B (de)
AT (2) ATE439590T1 (de)
AU (1) AU2004282754B9 (de)
CA (1) CA2542824C (de)
DE (1) DE602004022575D1 (de)
ES (2) ES2329582T3 (de)
MX (1) MXPA06004235A (de)
WO (1) WO2005038457A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
CA2545065C (en) * 2003-11-07 2012-07-17 Merck & Co., Inc. Method of identifying responders to treatment with insulin sensitizers
CA2614340A1 (en) * 2005-07-21 2007-06-07 Biovendor Laboratory Medicine, Inc. Method for determining the concentration of the adipocytic form of the fatty acid binding protein (a-fabp, fabp4, p2)
PL1976877T5 (pl) 2005-11-30 2017-09-29 Abbvie Inc Przeciwciała monoklonalne przeciwko białku amyloidu beta oraz ich zastosowania
RU2442793C2 (ru) 2005-11-30 2012-02-20 Эбботт Лэборетриз АНТИТЕЛА ПРОТИВ ГЛОБУЛОМЕРА Аβ, ИХ АНТИГЕНСВЯЗЫВАЮЩИЕ ЧАСТИ, СООТВЕТСТВУЮЩИЕ ГИБРИДОМЫ, НУКЛЕИНОВЫЕ КИСЛОТЫ, ВЕКТОРЫ, КЛЕТКИ-ХОЗЯЕВА, СПОСОБЫ ПОЛУЧЕНИЯ УКАЗАННЫХ АНТИТЕЛ, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ АНТИТЕЛА, ПРИМЕНЕНИЯ УКАЗАННЫХ АНТИТЕЛ И СПОСОБЫ ИСПОЛЬЗОВАНИЯ УКАЗАННЫХ АНТИТЕЛ
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
WO2009070350A1 (en) 2007-11-30 2009-06-04 Siemens Healthcare Diagnostics Inc. Adiponectin receptor fragments and methods of use
US20100330600A1 (en) 2008-02-29 2010-12-30 Sekisui Medical Co., Ltd. High-molecular-weight adiponectin measurement method
WO2009106838A1 (en) * 2008-02-29 2009-09-03 Isis Innovation Limited Diagnostic methods
EP2279418A2 (de) * 2008-05-20 2011-02-02 F. Hoffmann-La Roche AG Risikoanalyse bei patienten mit und ohne stoffwechselsyndrom
US9817001B2 (en) 2008-05-27 2017-11-14 Boston Heart Diagnostics Corporation Methods for determining LDL cholesterol treatment
JP2012502290A (ja) * 2008-09-11 2012-01-26 エフ．ホフマン−ラ ロシュ アーゲー メタボリックシンドロームを有する患者におけるナトリウム利尿ペプチドおよびアディポネクチン
US8470541B1 (en) 2008-09-27 2013-06-25 Boston Heart Diagnostics Corporation Methods for separation and immuno-detection of biomolecules, and apparatus related thereto
WO2010052334A1 (en) * 2008-11-10 2010-05-14 F. Hoffmann-La Roche Ag Relevance of intestinal adipocyte function in type 1 diabetes
EP2211182A1 (de) 2009-01-16 2010-07-28 Roche Diagnostics GmbH Verfahren zur Bewertung des Schweregrades einer Leberzirrhose
EP3444611A1 (de) 2009-04-23 2019-02-20 Siemens Healthcare Diagnostics Inc. Monomere und dimere formen von adiponectin-rezeptor-fragmenten sowie und verfahren zur verwendung davon
WO2010128657A1 (ja) 2009-05-07 2010-11-11 三菱化学メディエンス株式会社 高分子アディポネクチン分析のための新規モノクローナル抗体とその利用
WO2011130377A2 (en) 2010-04-15 2011-10-20 Abbott Laboratories Amyloid-beta binding proteins
JP5685777B2 (ja) * 2010-04-28 2015-03-18 株式会社エヌビィー健康研究所 バーチャルウエスタンブロッティングシステム
CA2800458A1 (en) 2010-06-15 2011-12-22 F. Hoffmann-La Roche Ag Prediction and recognition of acute kidney injury after surgery
US9062101B2 (en) 2010-08-14 2015-06-23 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
EP2392927A1 (de) 2011-03-11 2011-12-07 F. Hoffmann-La Roche AG Diagnose von Stoffwechselstörungen in HIV-infizierten Patienten
EP2385372A1 (de) 2011-06-21 2011-11-09 Roche Diagnostics GmbH Nierenerkrankung in einer normal und nicht normal verlaufenden Schwangerschaft
EP2568291A1 (de) 2011-09-07 2013-03-13 Roche Diagnostics GmbH L-FABP-basierte Diagnose eines Nierentraumas nach einem akuten Ereignis oder nach einem chirurgischen Eingriff
CA2851838A1 (en) 2011-10-13 2013-04-18 Boston Heart Diagnostics Corporation Compositions and methods for treating and preventing coronary heart disease
CN104737020B (zh) * 2012-08-30 2016-08-17 希森美康株式会社 早期肾障碍的评价指标和其测定方法
US20140120559A1 (en) 2012-10-26 2014-05-01 Boston Heart Diagnostics Corporation Diabetes panel
US9828624B2 (en) 2013-07-24 2017-11-28 Boston Heart Diagnostics Corporation Driving patient compliance with therapy
JP6512590B2 (ja) * 2014-08-25 2019-05-15 メカノジェニック株式会社 メタボリックシンドローム発症の危険性の予測方法
CA2968221A1 (en) 2014-11-17 2016-05-26 Boston Heart Diagnostic Corporation Cardiovascular disease risk assessment
AU2016290603B2 (en) * 2015-07-07 2022-06-02 Seqirus UK Limited Influenza potency assays
US11768209B2 (en) 2016-09-06 2023-09-26 Fujirebio Inc. Method and reagent for measuring thyroglobulin
US11802867B2 (en) 2016-09-13 2023-10-31 Fujirebio Inc. Cardiac troponin assay method and assay reagent
CN113631924A (zh) 2019-05-24 2021-11-09 富士瑞必欧株式会社 甲状腺球蛋白的测定方法和测定试剂
WO2021060450A1 (ja) 2019-09-27 2021-04-01 富士レビオ株式会社 Ｂ型肝炎ウイルスコア関連抗原のイムノアッセイ及びそのためのキット
CN111239421A (zh) * 2020-02-19 2020-06-05 安徽大千生物工程有限公司 一种定量检测脂联素adpn的胶乳增强免疫比浊试剂盒及其制备与应用方法
EP4130741B1 (de) 2020-03-31 2026-01-28 Fujirebio Inc. Verfahren zum immuntest von amyloid blut und kit dafür
CN111892907B (zh) * 2020-07-15 2021-11-02 广东省医疗器械研究所 一种白蛋白胶粘剂及其制备方法
JPWO2023013725A1 (de) 2021-08-06 2023-02-09
CN122029427A (zh) 2023-11-06 2026-05-12 富士瑞必欧株式会社 测定gpc3的方法及用于其的试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
JP4424775B2 (ja) 1999-04-21 2010-03-03 大塚製薬株式会社 抗原蛋白質の検出方法
CN1281981A (zh) * 1999-07-26 2001-01-31 武汉埃克玛生物技术有限公司 血清低密度脂蛋白测定试剂
CN1111201C (zh) * 1999-11-04 2003-06-11 孙续国 低密度脂蛋白受体检测试剂及方法
JP4458622B2 (ja) 2000-05-26 2010-04-28 積水メディカル株式会社 免疫学的測定方法及び測定用試薬
JP4547696B2 (ja) 2001-06-07 2010-09-22 第一三共株式会社 肝硬変予防・治療剤
DK1426764T3 (da) * 2001-08-17 2011-06-27 Fujirebio Kk Fremgangsmåde til diagnosticering eller monitorering af fejl i sukkermetabolisme

Also Published As

Publication number Publication date
CA2542824C (en) 2013-08-27
US8039223B2 (en) 2011-10-18
JPWO2005038457A1 (ja) 2007-01-18
CN1867828A (zh) 2006-11-22
AU2004282754A1 (en) 2005-04-28
EP2071333A3 (de) 2009-07-08
AU2004282754B2 (en) 2009-11-12
US20090291461A1 (en) 2009-11-26
ATE439590T1 (de) 2009-08-15
CA2542824A1 (en) 2005-04-28
WO2005038457A1 (ja) 2005-04-28
ES2383259T3 (es) 2012-06-19
KR20060132571A (ko) 2006-12-21
US7608405B2 (en) 2009-10-27
EP2071333B1 (de) 2012-04-18
EP1681566A1 (de) 2006-07-19
EP2071333A2 (de) 2009-06-17
US20070042424A1 (en) 2007-02-22
AU2004282754B9 (en) 2009-12-10
EP1681566A4 (de) 2007-05-02
CN1867828B (zh) 2010-09-29
ES2329582T3 (es) 2009-11-27
JP4677545B2 (ja) 2011-04-27
EP1681566B1 (de) 2009-08-12
MXPA06004235A (es) 2007-02-14
DE602004022575D1 (de) 2009-09-24
KR101206338B1 (ko) 2012-12-03

Similar Documents

Publication Publication Date Title
DE602004022575D1 (de) Verfahren zum selektiven testen von adiponectinmultimeren
DE69638004D1 (de) Protein-färbung mittels merocyanin farbstoffe
ATE509120T1 (de) Fusionsproteine zur detektion von analyten
DE60140773D1 (de) Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS)
EP1687283A4 (de) Für die bestimmung von fk506 geeignetes verfahren und zusammensetzung
EP1289553A4 (de) Nrg-2 nukleinsäuren, polypeptide und diagnostische / therapeutische methoden
EP1623227A4 (de) Proteine, sensoren und verfahren zur charakterisierung von analyten damit
DE69841037D1 (de) Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung.
DE59903915D1 (de) Verfahren zur frühen diagnose von carcinomen
DE60333471D1 (de) Polyklonaler-monoklonaler-elisa-assay zum nachweis von n-terminalem probnp
MX9200709A (es) Activacion mejorada de proteinas recombinadas. activacion mejorada de proteinas recombinadas.
ATE327511T1 (de) Proteom-analyseverfahren
ATE322688T1 (de) Verfahren zur bestimmung der nitrosylierung von proteinen
SE8802944L (sv) Material foer lapptestning
DK0946873T3 (da) Fremgangsmåde til diagnose af allergisk bronkopulmonal aspergillose
Crettaz et al. Proteomics of methylene blue photo‐treated plasma before and after removal of the dye by an absorbent filter
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
ATE462001T1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
DE60203599D1 (de) Methode zur Inaktivierung von TSE
IL162568A0 (en) fluorescent protein from aequorea coerulscens and uses thereof
EP1560025A3 (de) Marker spezifisch für Diabetes
BRPI0406265A (pt) Método para análise eletroforética capilar, métodos para pesquisa e tipagem de proteìnas monoclonais, processo para preparação de anticorpos modificados, anticorpos modificados, kit para detecção e tipagem de proteìnas monoclonais e uso de anticorpos
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
ATE383418T1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
Kustos et al. Effect of iron restriction on outer membrane protein composition of Pseudomonas strains studied by conventional and microchip electrophoresis